Cargando…

Increased plasma concentrations of interleukin 35 in patients with coronary artery disease

INTRODUCTION: Atherosclerosis leading to coronary artery disease (CAD) is a chronic inflammatory condition. Interleukin 35 (IL-35) released by regulatory T cells (Tregs) has been found to be associated with CAD in the Chinese population. However, nothing is known about the relation between IL-35 con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gorzelak-Pabiś, Paulina, Chalubinski, Maciej, Wojdan, Katarzyna, Luczak, Emilia, Duraj, Iwona, Mozdzan, Monika, Broncel, Marlena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2016
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510518/ https://www.ncbi.nlm.nih.gov/pubmed/28721145 http://dx.doi.org/10.5114/aoms.2016.63751

Ejemplares similares

The effect of melatonin on circadian blood pressure in patients with type 2 diabetes and essential hypertension
por: Możdżan, Monika, et al.
Publicado: (2014)

Comprehensive insight into immune regulatory mechanisms and vascular wall determinants of atherogenesis – emerging perspectives of immunomodulation
por: Chalubinski, Maciej, et al.
Publicado: (2013)

The effect of 7-ketocholesterol and 25-hydroxycholesterol on the integrity of the human aortic endothelial and intestinal epithelial barriers
por: Chalubinski, Maciej, et al.
Publicado: (2013)

Sleep changes following statin therapy: a systematic review and meta-analysis of randomized placebo-controlled polysomnographic trials
por: Broncel, Marlena, et al.
Publicado: (2015)

Short-term supplementation with Aronia melanocarpa extract improves platelet aggregation, clotting, and fibrinolysis in patients with metabolic syndrome
por: Sikora, Joanna, et al.
Publicado: (2011)

The Protective Effect of Dabigatran and Rivaroxaban on DNA Oxidative Changes in a Model of Vascular Endothelial Damage with Oxidized Cholesterol
por: Woźniak, Ewelina, et al.
Publicado: (2020)

A comparison of the effects of monotherapy with rosuvastatin, atorvastatin or ezetimibe versus combination treatment with rosuvastatin-ezetimibe and atorvastatin-ezetimibe on the integrity of vascular endothelial cells damaged by oxidized cholesterol
por: Niedzielski, Mateusz, et al.
Publicado: (2021)

Neuroprotective Effect of SGLT2 Inhibitors
por: Pawlos, Agnieszka, et al.
Publicado: (2021)

Elevated Lp(a) and course of COVID-19: Is there a relationship?
por: Pawlos, Agnieszka, et al.
Publicado: (2022)

Cardiovascular risk and response to lipid lowering therapy in patients with HIV infection according to different recommendations
por: Pawlos, Agnieszka, et al.
Publicado: (2020)

COVID-19: Direct and Indirect Mechanisms of Statins
por: Pawlos, Agnieszka, et al.
Publicado: (2021)

The effect of lipid-lowering therapies on the pro-inflammatory and anti-inflammatory properties of vascular endothelial cells
por: Woźniak, Ewelina, et al.
Publicado: (2023)

Euthyroid Sick Syndrome as a Prognostic Indicator of COVID-19 Pulmonary Involvement, Associated With Poorer Disease Prognosis and Increased Mortality
por: Świstek, Magdalena, et al.
Publicado: (2022)

SGLT2 Inhibitors May Restore Endothelial Barrier Interrupted by 25-Hydroxycholesterol
por: Pawlos, Agnieszka, et al.
Publicado: (2023)

Severe COVID-19 classified by simple covid risk index is associated with higher levels of advanced oxidation protein products and 8-hydroxy 2 deoxyguanosine
por: Satała, Joanna, et al.
Publicado: (2023)

Effect of statins on platelet function in patients with hyperlipidemia
por: Sikora, Joanna, et al.
Publicado: (2013)

Disorders of erythrocyte structure and function in hypertensive patients
por: Pytel, Edyta, et al.
Publicado: (2012)

Antibodies towards TVLLPVIFF Amino Acid Sequence of TNF Receptor Induced by Helicobacter pylori in Patients with Coronary Heart Disease
por: Gonciarz, Weronika, et al.
Publicado: (2022)

Searching for serum biomarkers linking coronary heart disease and Helicobacter pylori infection using infrared spectroscopy and artificial neural networks
por: Gonciarz, Weronika, et al.
Publicado: (2022)

Echocardiographic indices of left ventricular hypertrophy and diastolic function in hypertensive patients with preserved LVEF classified as dippers and non-dippers
por: Możdżan, Monika, et al.
Publicado: (2013)

Putative consequences of exposure to Helicobacter pylori infection in patients with coronary heart disease in terms of humoral immune response and inflammation
por: Matusiak, Agnieszka, et al.
Publicado: (2016)

Rapid Communication: Plasma Interleukin-35 in Children with Autism
por: Rose, Destanie, et al.
Publicado: (2019)

The Role of Defective Epithelial Barriers in Allergic Lung Disease and Asthma Development
por: Noureddine, Nazek, et al.
Publicado: (2022)

Sulfenamide and Sulfonamide Derivatives of Metformin – A New Option to Improve Endothelial Function and Plasma Haemostasis
por: Markowicz-Piasecka, Magdalena, et al.
Publicado: (2019)

The Relationship Between Serum Concentration of Interleukin-35 and FoxP3 Polymorphism in Patients Undergoing Coronary Artery Bypass Graft Surgery
por: Dasturian, Farzaneh, et al.
Publicado: (2020)

Heart rhythm turbulence and NT-proBNP in decompensated liver cirrhosis – a pilot study
por: Poliwczak, Adam Rafał, et al.
Publicado: (2011)

Serum Chemerin Concentration Is Associated with Proinflammatory Status in Chronic Coronary Syndrome
por: Szpakowicz, Anna, et al.
Publicado: (2021)

Plasma Concentrations of Matrilysins MMP-7 and MMP-26 as Diagnostic Biomarkers in Breast Cancer
por: Piskór, Barbara Maria, et al.
Publicado: (2021)

Comparison of serum concentrations of interleukins 10, 12, 17 and 35 between patients with alopecia areata and controls
por: Wojciechowska-Zdrojowy, Marta, et al.
Publicado: (2022)

The Role, Involvement and Function(s) of Interleukin-35 and Interleukin-37 in Disease Pathogenesis
por: Omenesa Bello, Ramatu, et al.
Publicado: (2018)

Interleukin-35 as an Emerging Player in Tumor Microenvironment
por: Xue, Wenhua, et al.
Publicado: (2019)

Immunomodulatory cytokine interleukin-35 and immune thrombocytopaenia
por: Zhu, Jing-Jing, et al.
Publicado: (2020)

Pathogenesis and Function of Interleukin-35 in Rheumatoid Arthritis
por: Xin, Pan Lin, et al.
Publicado: (2021)

Interleukin-35 in autoimmune dermatoses: Current concepts
por: Xie, Yuming, et al.
Publicado: (2022)

Elevated Plasma Interleukin-35 as a Prognostic Indicator in Localized Clear Cell Renal Cell Carcinoma
por: Zhang, Jun, et al.
Publicado: (2022)

Plasma interleukin-27 levels in patients with coronary artery disease
por: Miura, Kotaro, et al.
Publicado: (2017)

Aronia melanocarpa Elliot Reduces the Activity of Angiotensin I-Converting Enzyme—In Vitro and Ex Vivo Studies
por: Sikora, Joanna, et al.
Publicado: (2014)

Plasma interleukin 8 concentrations in obese subjects with impaired glucose tolerance.
por: Straczkowski, Marek, et al.
Publicado: (2003)

Choice of anesthetic technique on plasma concentrations of interleukins and cell adhesion molecules
por: Ionescu, Daniela C, et al.
Publicado: (2013)

Interleukin 35 Polymorphisms Are Associated with Decreased Risk of Premature Coronary Artery Disease, Metabolic Parameters, and IL-35 Levels: The Genetics of Atherosclerotic Disease (GEA) Study
por: Posadas-Sánchez, Rosalinda, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mgsgb5d1c5fu1bj9qhe90l9dp9